In 2023, the global R&D budget for health and medical sciences as a percentage of GDP varied significantly across countries. Sweden led with the highest allocation at 0.25%, followed by the United States (0.2%) and the Netherlands (0.19%). Among the notable year-on-year changes, Japan experienced a substantial increase of 6.44%, while Finland and Romania saw sharp declines of -31.07% and -27.77%, respectively. The United States and France registered slight decreases, while other countries such as Norway, Austria, and Germany showed moderate growth.
Future trends to watch include potential recovery and budget increases in countries that experienced significant declines, such as Finland and Romania. Additionally, countries with current high growth rates, like Japan, could further enhance their commitments, thereby reshaping the landscape of global R&D investment in health and medical sciences.
Top countries in R&D Budget for Health and Medical Sciences by Country
| # | 10 Countries | Percent of GDP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Sweden | 0.25 | 2023 | +4.8% | +3.86% | View data |
| 2 | 2 United States | 0.2 | 2023 | -0.22% | -0.16% | View data |
| 3 | 3 Netherlands | 0.19 | 2023 | +0.41% | +0.63% | View data |
| 4 | 4 Norway | 0.17 | 2023 | +1.92% | +2.42% | View data |
| 5 | 5 Austria | 0.17 | 2023 | +1.75% | +2.64% | View data |
| 6 | 6 Germany | 0.16 | 2023 | +1.33% | +1.66% | View data |
| 7 | 7 Taiwan | 0.15 | 2023 | +0.28% | +0.3% | View data |
| 8 | 8 Denmark | 0.13 | 2023 | +1.27% | +1.04% | View data |
| 9 | 9 Luxembourg | 0.11 | 2023 | +1.14% | +1.33% | View data |
| 10 | 10 France | 0.082 | 2023 | -1.48% | -1.06% | View data |
